These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3805873)

  • 1. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy.
    Cacciola E; Giustolisi R; Musso R; Vecchio R; Longo A; Triolo A; Cacciola RR
    J Lab Clin Med; 1987 Feb; 109(2):225-6. PubMed ID: 3805873
    [No Abstract]   [Full Text] [Related]  

  • 2. Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy.
    Musso R; Longo A; Triolo A; Giustolisi R; Cacciola RR; Cacciola E; Vecchio R; Russo A; Magnano A
    Gastrointest Endosc; 1987 Oct; 33(5):400-2. PubMed ID: 3678776
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Initiation of blood coagulation].
    Saito H
    Rinsho Byori; 1985 Sep; 33(9):960-5. PubMed ID: 3878416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of immobilized noradrenaline on the contact phase of blood coagulation].
    Zubairov DM; Popova LG; Zinkevich OD; Konchurina GIu
    Vopr Med Khim; 1977; 23(4):473-8. PubMed ID: 919370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship among coagulation, fibrinolysis, kinin formation and factor XII].
    Saito H
    Rinsho Ketsueki; 1978 Jun; 19(6):785-91. PubMed ID: 713043
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of the sclerosing agent "hydroxypolyaetoxydodecan" on the coagulation potentials: in vitro investigations.
    Wuppermann T; Haas KH
    Vasa; 1975; 4(1):45-53. PubMed ID: 1189590
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of adrenaline on the contact phase of blood coagulation].
    Ratmanova VI
    Fiziol Zh SSSR Im I M Sechenova; 1976 May; 62(5):699-702. PubMed ID: 1278548
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of local sclerosing agents on hemostasis of hepatic bleeding.
    Aysan E; Basak F; Kinaci E; Tutuncu H
    Hepatogastroenterology; 2007 Jun; 54(76):1212-5. PubMed ID: 17629072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation of the contact system of human plasma by polysaccharide sulfates.
    Silverberg M; Diehl SV
    Ann N Y Acad Sci; 1987; 516():268-79. PubMed ID: 2449841
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.